drugset / Trial / NCT02393482

Psychological Impact of Amenorrhea in Women With Endometriosis

NCT02393482

Phase 4 Unknown 50 enrolled University of Cagliari
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the impact on quality of life, psychological health, sexuality and chronic pain of therapies which determine amenorrhea in symptomatic women with endometriosis, through the administration of self reported questionnaires. Amenorrhea in the first group is caused by balanced assumption of estroprogestins, in the second group is caused by GnRHa-induced hypoestrogenism.

Timeline

Start
2021-06
Primary completion
2021-12
Completion
2022-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Leuprolide Other / unclassified 3.75 mg Intramuscular
Comparator Levonorgestrel Small molecule 20 ug Oral
Comparator etinilestradiol Unknown 100 ug Oral
Comparator Calcium carbonate Other / unclassified 500 mg Oral
Comparator Cholecalciferol Other / unclassified 400 iu Oral
Comparator Tibolone Other / unclassified 5 mg Oral